REFERENCES
- Murakami H., Kawashima Y., Yukiniwa T., Akihiro T., Takichuic H., Kobayashi M. Int. J. Pharm. 1997; 149: 43
- Almeida A. J., Runge S., Muller R. H. Int. J. Pharm. 1996; 149: 256
- Borchard G., Audus K. L., Fenglinshi S., Kreuter J. Int. J. Pharm. 1994; 110: 29
- Rajanarivony M., Vauthier C., Couarraze G., Puisieux F., Couvreur P. J. Pharm. Sci. 1992; 82: 910
- Halbert G. W., Stuart J. F. B., Florence S. T. J. Cancer Chemother., Pharmacol. 1985; 15: 223–227
- Utsumi S., Shinomiya H., Minami J., Sonoda S. Immunology 1983; 49: 113–120
- Kim C., Lee M., Han J.-H., Lee B.-J. Int. J. Pharm. 1994; 108: 21–29
- Couvreur P., Kante B., Roland M., Speiser P. P. J. Pharm. Sci. 1979; 68: 1521–1524
- Burgess D. J., Hicky A. J. Microsphere technology and applications to nuclear magnetic resonance in pharmaceutical technology. Encyclopedia of Pharmaceutical Technology, J. Swarbrick, J. C. Boylan. 10th ed., Marcel Dekker, New York 1994; 167
- Lin W., Coombes A. G. A., Davies M. C., Davis S. S., Illum L. J. Drug Targeting 1993; 1: 237–243
- Fawaz F., Guyot M., Lagueny A. M., Devissuguet J. Ph. Int. J. Pharm. 1999; 154: 195
- Bickel M. H., Weder H. J. Arch. Int. Pharmacodyn. 1968; 173: 433–463